REAL-WORLD DATA ON THE TREATMENT OF SICKLE CELL DISEASE WITH VOXELOTOR: RESULTS FROM A BRAZIL'S EARLY ACCESS PROGRAM
a Department of Hematoloty/Oncology, Hospital Samaritano, São Paulo, Brazil
b Regional Blood Center, Faculdade de Medicina de Ribeirão Preto (FMRP), Universidade de São Paulo (USP), Ribeirão Preto, Brazil
c Department of Hematology, Fundação de Hematologia e Hemoterapia de Pernambuco (HEMOPE), Recife, Brazil
d Department of Clinical Research, Instituto Estadual de Hematologia Arthur de Siqueira Cavalcanti (Hemorio), Rio de Janeiro, Brazil
e Department of Clinical and Experimental Oncology, Escola Paulista de Medicina (EPM), Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil
Read
238
Timeswas read the article
137
Total PDF
101
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2024 May | 18 | 16 | 34 |
| 2024 April | 21 | 15 | 36 |
| 2024 March | 20 | 23 | 43 |
| 2024 February | 16 | 15 | 31 |
| 2024 January | 5 | 10 | 15 |
| 2023 December | 8 | 20 | 28 |
| 2023 November | 13 | 28 | 41 |
| 2023 October | 0 | 10 | 10 |
